Patent 6015671 Issued on January 18, 2000. Estimated Expiration Date: November 21, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
435/6, Involving nucleic acid435/354, Mouse (i.e., Mus)435/366, Human435/377, Method of altering the differentiation state of the cell435/465Involving co-transfection
Described are preferred myocardial grafts of skeletal myoblasts or cardiomyocytes, and cellular compositions and methods useful in obtaining the grafts. The myocardial grafts are stable and can be used, for example, to deliver recombinant proteins directly to the heart.
Other References
Shen et al., Int. J. Dev. Biol. , vol. 36, 1992, pp. 465-47
November 21, 2017. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
